Cipla invests extra $3 mn in Chase Pharmaceuticals
17 March 2016 | News | By BioSpectrum Bureau
Cipla invests extra $3 mn in Chase Pharmaceuticals
Cipla UK's total investment in Chase would aggregate to approximately $5.12 million
"Cipla (EU) Limited, UK ("Cipla UK"), a wholly owned subsidiary of the Company, has pursuant to the approval of the board of Cipla UK, made an additional investment of $3 million in Chase Pharmaceuticals Corporation US ("Chase") towards full settlement of its obligation under the agreed arrangement for investment in Chase," Cipla said in a filing to BSE
"Consequently, Cipla UK's total investment in Chase would aggregate to approximately $5.12 million for a 16.7 percent stake on a fully diluted basis," it added.
The company in May 2014 had invested $1.5 million to acquire 14.6 percent stake in Chase Pharmaceuticals.
